project id: TCGA-ESCA; case submitter id: TCGA-VR-AA4G; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 7.3; age at index: 51; days to birth: -18909; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1962; age at diagnosis: 18909; ajcc clinical m: M0; ajcc clinical n: N2; ajcc clinical stage: Stage IIIA; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 549.0; icd 10 code: C15.4; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Middle third of esophagus; synchronous malignancy: No; tissue or organ of origin: Middle third of esophagus; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: No; cigarettes per day: 0.547945205479452; pack years smoked: 10.0; is ffpe: false; composition: Not Reported; days to collection: 190; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-VR-AA4G-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 8.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 10.0; percent stromal cells: 40.0; percent tumor cells: 50.0; percent tumor nuclei: 80.0;